scholarly journals Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer

2017 ◽  
Vol 92 (10) ◽  
pp. 1564-1582 ◽  
Author(s):  
Karthik V. Giridhar ◽  
Manish Kohli
2016 ◽  
Vol 9 (1) ◽  
pp. 33-45 ◽  
Author(s):  
Sujata Narayanan ◽  
Sandy Srinivas

Patients with relapsed or refractory urothelial carcinoma (UC) have poor prognosis coupled with few options for systemic treatment. The role of angiogenesis in the evolution of cancers has been established, and studies have shown that it plays a key role in the pathogenesis of UC. Many targeted agents have been used in phase I–II trials for the treatment of UC, with encouraging but modest results. Recently, studies combining angiogenesis inhibitors with other chemotherapeutic agents were able to achieve objective responses higher than most commonly used second-line therapies in UC. Future efforts in investigating these therapies in UC rely on identification of biomarkers and other predictors of response to anti-VEGF therapy.


2018 ◽  
Vol 16 (3) ◽  
pp. e637-e644 ◽  
Author(s):  
Steven M. Yip ◽  
Jeenan Kaiser ◽  
Haocheng Li ◽  
Scott North ◽  
Daniel Y.C. Heng ◽  
...  

2019 ◽  
Vol 123 (6) ◽  
pp. 947-958 ◽  
Author(s):  
Emma Doyle ◽  
Jeremy Crew ◽  
Hugh Mostafid ◽  
Mark Tuthill ◽  
Vincenzo Cerundolo ◽  
...  

2007 ◽  
Vol 101 (8) ◽  
pp. 937-943 ◽  
Author(s):  
Guru Sonpavde ◽  
Robert Ross ◽  
Thomas Powles ◽  
Christopher J. Sweeney ◽  
Noah Hahn ◽  
...  

2020 ◽  
Vol 20 (9) ◽  
pp. 755-763 ◽  
Author(s):  
Veronica Mollica ◽  
Ilaria Maggio ◽  
Antonio Lopez-Beltran ◽  
Rodolfo Montironi ◽  
Alessia Cimadamore ◽  
...  

2020 ◽  
Vol 23 (10) ◽  
Author(s):  
Noora M Kareem ◽  
Dalya Basil Hanna ◽  
Asmaa B Al-Obaidi ◽  
Haider Faisel Ghazi
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document